Influence of monoacylglycerol lipase on growth of nude mice xenograft tumor of human hepatocellular carcinoma and related mechanism
-
摘要: 目的探讨单酰甘油脂肪酶(MAGL)在人肝细胞癌(HCC)裸鼠移植瘤生长中的作用和机制。方法移植的SMMC-7721细胞株分为SMMC-7721WT组(未处理)、SMMC-7721MAGL-KD组(MAGL沉默)、SMMC-7721MAGL-OE组(MAGL过表达)和SMMC-7721Vector组(空载体转染) 4组。将27只雄性BALB/c裸鼠分为4组建立裸鼠皮下移植瘤模型,即A组(注射SMMC-7721WT组细胞株,n=12)、B组(注射SMMC-7721MAGL-KD组细胞株,n=5)、C组(注射SMMC-7721MAGL-OE组细胞株,n=5)及D组(注射SMMC-7721Vector组细胞株,n=5),其中A组又分为A1(正常饲喂,n=4)、A2[(高脂饲喂(HFD)+JZL184(MAGL的特异性抑制剂,n=4)和A3 (HFD饲喂,n=4) 3个亚组。观察并比较4组肿瘤体积变化,瘤体内增殖细胞核抗原...
-
关键词:
- 癌,肝细胞 /
- 单酰基甘油酯脂酶类 /
- 小鼠,近交BALB C
Abstract: Objective To investigate the role and mechanism of action of monoacylglycerol lipase ( MAGL) on the growth of nude mice xenograft tumor of human hepatocellular carcinoma ( HCC) . Methods The transplanted SMMC-7721 cells were divided into SMMC-7721 WT group ( without treatment) , SMMC-7721 MAGL-KDgroup ( with MAGL silencing) , SMMC-7721 MAGL-OEgroup ( with MAGL overexpression) , and SMMC-7721 Vectorgroup ( transfected with empty vector) . A total of 27 male BALB/c nude mice were randomly divided into group A ( 12 mice injected with the cells in the SMMC-7721 WTgroup) , group B ( 5 mice injected with the cells in the SMMC-7721 MAGL-KD group) , group C ( 5 mice injected with the cells in the SMMC-7721 MAGL-OEgroup) , and group D ( 5 mice injected with the cells in the SMMC-7721 Vectorgroup) . The mice in group A were further divided into groups A1 ( control group) , A2 ( treated with high-fat diet and JZL184, a specific inhibitor of MAGL) , and A3 ( fed with high-fat diet) , with 4 mice in each group. The four groups were compared in terms of the change in tumor volume and the expression of proliferating cell nuclear antigen ( PCNA) , metal matrix proteinase-2 ( MMP-2) , lysophosphatidic acid ( LPA) , and prostaglandin E2 ( PGE2) in tumor. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the SNK-q test was used for further comparison between two groups. Results There was a significant difference in the relative protein expression of MAGL between the SMMC-7721 WTgroup, the SMMC-7721 MAGL-KDgroup, and the SMMC-7721 MAGL-OEgroup ( 0. 377 ± 0. 026 vs 0. 182 ± 0. 055 vs 0. 689 ± 0. 019, F = 33. 382, P < 0. 001) ; compared with the SMMC-7721 WTgroup, the SMMC-7721 MAGL-KDgroup had significantly lower protein expression of MAGL and the SMMC-7721 MAGL-OEgroup had significantly higher expression ( P < 0. 05) . There was a significant difference in the size of subcutaneous xenograft tumor between groups A, B, C, and D ( 4236. 125 ± 1284. 283 mm3 vs 1883. 375 ± 552. 977 mm3 vs 10 146. 061 ± 1842. 264 mm3 vs 4307. 452 ± 2070. 708 mm3, F= 6. 804, P = 0. 023) . Group C had a lower growth rate of subcutaneous xenograft tumor than group A ( P < 0. 05) , and group B had a higher growth rate than group A ( P < 0. 05) . There were significant differences between groups A, B, and C in the levels of PCNA ( 25 843.821 ± 4201. 310 vs 17 426. 95 ± 5139. 202 vs 39 753. 103 ± 5721. 444, F = 21. 482, P < 0. 001) and MMP-2 ( 52 841. 621 ± 4339. 253 vs35 511. 451 ± 8251. 423 vs 68 274. 731 ± 6418. 594, F = 11. 526, P < 0. 001) ; group B had significantly lower levels of PCNA and MMP-2 than group A ( P < 0. 05) , and group C had significantly higher levels than group A ( P < 0. 05) . There was a significant difference in tumor volume between groups A1, A2, and A3 ( 23 476. 289 ± 483. 872 mm3 vs 18 593. 851 ± 1385. 805 mm3 vs 37 703. 198 ± 2925. 254 mm3, F = 47. 371, P = 0. 004) . Compared with group A1, group A3 had a significantly higher growth rate of subcutaneous xenograft tumor ( P < 0. 05) and group A2 had a significantly lower growth rate ( P < 0. 05) . There was a significant difference in the level of PGE2 between groups A1, A2, and A3 ( 0. 109 ± 0. 023 μmol/L vs 0. 056 ± 0. 010 μmol/L vs 0. 168 ± 0. 024 μmol/L, F = 16. 492, P < 0. 001) ; group A3 had a significantly higher level of PGE2 than group A1 ( P < 0. 05) , and group A2 had a significantly lower level than group A1 ( P < 0.05) . There was a significant difference in the level of PGE2 between groups B, C, and D ( 0. 069 ± 0. 025 μmol/L vs 0. 175 ± 0. 023 μmol/L vs 0. 096 ± 0. 019 μmol/L, F = 31. 550, P < 0. 001) ; group B had a significantly lower level of PGE2 than group D ( P < 0. 05) , and group C had a significantly higher level than group D ( P < 0. 05) . Conclusion MAGL can promote the growth of subcutaneous xenograft tumor of HCC by regulating PGE2, suggesting that MAGL might become a potential target for HCC treatment in future.-
Key words:
- carcinoma, hepatocellular /
- monoacylglycerol lipases /
- mice, inbred BALB C
-
[1]BRAY F, FERLAY J, JEMAL A, et al.Global cancer statistics2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018, 68 (6) :394-424. [2]CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2) :115-32. [3]ZHANG C, WANG J.Experience in treating hepatocellular carcinoma by classical pescription[J].J Changchun Univ Chin Med, 2018, 34 (5) :908-910. (in Chinese) 张驰, 王军.原发性肝细胞癌经方论治管见[J].长春中医药大学学报, 2018, 34 (5) :908-910. [4]XU M, ZHENG XM, QIU WQ, et al.MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease[J].J Cel Biochem, 2018, 119 (7) :5864-5874. [5] TORNQVIST H, BELFRAGE P.Purification and some properties of a monoacylglycerol hydrolyzing enzyme of rat adipose tissue[J].Biol Chem, 1976, 251 (3) :813-819. [6]GUZMAN M.A new age for MAGL[J].Chem Biol, 2010, 17 (1) :4-6. [7]NOMURA DK, LONG JZ, CRAVATT BF, et al.Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis[J].Cell, 2010, 140 (1) :49-61. [8] CIPRIANO M, GOUVEIA-FIGUEIRA S, FOWLER CJ, et al.The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells[J].BMC Res Notes, 2014, (7) :441. [9]QIN H, RUAN ZH.The role of monoacylglycerol lipase (MAGL) in the cancer progress[J].Cell Biochem Biophys, 2014, 70 (1) :33-36. [10]CHEN XF, ZHANG JY, XU ZP, et al.LPSS-NH2-medicated transfection of) monoacylglycerol) lipase) shRNA) down-regulates prostaglandin) E2) and) inhibits proliferation and) invasion in hepatocellular cell lines[J].J Third Milit Med Univ, 2018, 40 (19) :1762-1769. (in Chinese) 陈先锋, 张俊勇, 龚建平, 等.硅酸盐介孔材料介导的MAGL-shRNA转染下调前列腺素E2抑制肝细胞癌细胞株增殖与侵袭[J].第三军医大学学报, 2018, 40 (19) :1762-1769. [11]NIU D, ZHANG J, GONG J.et al.Monodispersed and ordered large-pore mesoporous silica nanospheres with tunable pore structure for magnetic functionalization and gene delivery[J].Adv Mater, 2014, 26 (29) :4947-4953. [12] JAUREGUIBERRY MS, TRICERRI M, RIMOLDI OJ, et al.Role of plasma membrane lipid composition on cellular homeostasis:Learning from cell line models expressing fatty acid desaturases[J].Acta Biochim Biophys Sin (Shanghai) , 2014, 46 (4) :273-282. [13] ZHANG J, GONG JP, QIAO ZR, et al.The combined antitumor effects of 125I radioactive particle implantation and cytokine-induced killer cell therapy on xenograft hepatocellular carcinoma in a mouse model[J].Technol Cancer Res Treat, 2017, 16 (6) :1083-1091. [14] ZHANG J, LIU ZJ, GONG JP, et al.Monoacylglycerol lipase:A novel potential therapeutic target and prognostic indicator for hepatocellular carcinoma[J].Sci Rep, 2016, 6:35784. [15] SUN H, JIANG L, HUANG Y, et al.Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer[J].Oncogene, 2013, 32 (2) :234-241. [16]PAGANO E, BORRELLI F, ORLANDO P, et al.Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis[J].Pharmacol Res, 2017, (119) :227-236. [17]TANG ED, WANG CY.YAP-mediated induction of monoacylglycerol lipase restrains oncogenic transformation[J].Cell Signal, 2015, 27 (4) :836-840. [18] LLOYD PG.Caveolin-1, antiapoptosis signaling, and anchorage-independent cell growth.Focus on"Caveolin-1regulates Mcl-1 stability and anoikis in lung carcinoma cells"[J].Am J Physiol Cell Physiol, 2012, 302 (9) :c1282-c1283. [19] ZHU W, ZHAO Y, WANG L, et al.Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition[J].J Hematol Oncol, 2016, 9 (1) :127. [20] REN J, XIAO YJ, XU Y, et al.Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells[J].Cancer Res, 2006, 66 (6) :3006-3014. [21]MAZZOCCA A, ANTONACI S, GIANNELLI G.Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts[J].Hepatology, 2011, 54 (3) :920-930. [22]ZHANG H, BAI X, LENG J, et al.Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression[J].Int J Oncol, 2014, 44 (3) :769-780. [23]NOMURA D, CAROLYN H, ANNA W, et al.Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels[J].Bioorg Med Chem Lett, 2008, 18 (22) :5875-5878. [24] MACCARRONE M, DI RIENZO M, FINAZZI-AGRA, et al.Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells[J].Biochem J, 2002, 366 (Pt1) :137-144. [25] HU WR, LIAN YF, ZENG YX, et al.Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma[J].Int JClin Exp Pathol, 2014, 7 (7) :3704-3713. [26]CHAI C, RIVKIN M, GALUN E, et al.Metabolic circuit involving free fatty acids, microrna 122, and triglyceride synthesis in liver and muscle tissues[J].Gastroenterology, 2017, 153 (5) :1404-1415. [27] PACELLA I, BARNABA V, PICONESE S, et al.Fatty acid metabolism complements glycolysis in the selective regulatory Tcell expansion during tumor growth[J].Proc Natl Acad Sci US A, 2018, 115 (28) :e6546-e6555. [28] JAUREGUIBERRY MS, TRICERRI M, RIMOLDI OJ, et al.Role of plasma membrane lipid composition on cellular homeostasis:learning from cell line models expressing fatty acid desaturases[J].Acta Biochim Biophys Sin (Shanghai) , 2014, 46 (4) :273-282. [29] MAZZOCCA A, ANTONACI S, GIANNELLI G.Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts[J].Hepatology, 2011, 54 (3) :920-930. [30] ZHANG H, BAI X, LENG J, et al.Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression[J].Int J Oncol, 2014, 44 (3) :769-780.
本文二维码
计量
- 文章访问数: 1276
- HTML全文浏览量: 16
- PDF下载量: 294
- 被引次数: 0